No excess long‐term mortality in stage I‐IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy-Reference-Cited by-同舟云学术

No excess long‐term mortality in stage I‐IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy

Published:2019-10-14 Issue:5 Volume:188 Page:685-691
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Lagerlöf Ingemar¹^ORCID,Holte Harald²³^ORCID,Glimelius Ingrid¹^ORCID,Björkholm Magnus⁴,Enblad Gunilla¹,Erlanson Martin⁵,Fluge Øystein⁶,Fohlin Helena⁷,Fosså Alexander²³,Goldkuhl Christina⁸,Gustavsson Anita⁹,Johansson Ann‐Sofie⁵,Linderoth Johan⁹,Nome Ole²,Palma Marzia¹⁰,Åkesson Lisa⁷,Østenstad Bjørn²,Raud Cecilia¹,Glimelius Bengt¹,Molin Daniel¹

Affiliation:

1. Experimental and Clinical Oncology Department of Immunology, Genetics and Pathology Uppsala University Uppsala Sweden

2. Department of Oncology Oslo University Hospital OsloNorway

3. KG Jebsen Centre for B cell malignancies Oslo Norway

4. Department of Medicine Division of Haematology Karolinska University Hospital Solna StockholmSweden

5. Department of Oncology Umeå University Umeå Sweden

6. Department of Oncology and Medical Physics Haukeland University Hospital Bergen Norway

7. Regional Cancer Centre South East Sweden and Department of Clinical and Experimental Medicine Linköping University LinköpingSweden

8. Department of Oncology Sahlgrenska University Hospital GothenburgSweden

9. Department of Clinical Sciences Division of Oncology and Pathology, Lund University Lund Sweden

10. Lymphoma Unit Department of Haematology Karolinska University Hospital Solna Stockholm Sweden

Funder

Cancerfonden

Uppsala Universitet

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16232

Reference27 articles.

1. Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma

2. Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors-Retrospective cohort analyses and a concept for prospective intervention

3. Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

4. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

5. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific Issues

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term cause‐specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens—A nationwide Danish cohort study;British Journal of Haematology;2024-06-12

2. Stable use of radiotherapy in lymphoma patients over time – A comprehensive national overview of radiotherapy use in Sweden with focus on older patients;Clinical and Translational Radiation Oncology;2024-05

3. Contemporary radiation therapy use in Hodgkin lymphoma;Seminars in Hematology;2024-05

4. Most common health problems in general practice among adolescents, and young adults’ survivors of lymphoma: a register-based cohort study in Norway;Acta Oncologica;2023-10-28

5. Chronic fatigue in long-term survivors of Hodgkin’s lymphoma after contemporary risk-adapted treatment;Acta Oncologica;2023-01-02